Inventor · disambiguated record
Jennifer R. Downing
Also filed as: DOWNING JENNIFER · DOWNING JENNIFER R
11 granted patents·5 pending applications·16 citations·filing 2018–2024
85Inventor score
Files withFORMA THERAPEUTICS INC8BOEHRINGER INGELHEIM INT3RIBON THERAPEUTICS INC3VALO EARLY DISCOVERY INC1VALO HEALTH INC1
Top patents by PatentIndex Score
16 records- 0194US10870648B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·8 cites·24 claims
- 0293US11535621B2Heterobicyclic amides as inhibitors of CD38RIBON THERAPEUTICS INC·Filed 2020·Granted Dec 27, 2022·3 cites·4 claims
- 0392US11987584B2Heterobicyclic amides as inhibitors of CD38RIBON THERAPEUTICS INC·Filed 2022·Granted May 21, 2024·1 cites·22 claims
- 0491US11254674B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·2 cites·21 claims
- 0589US11952377B2Quinolines and azaquinolines as inhibitors of CD38BOEHRINGER INGELHEIM INT·Filed 2022·Granted Apr 9, 2024·1 cites·9 claims
- 0683US12398146B2Heterobicyclic amides as inhibitors of CD38BOEHRINGER INGELHEIM INT·Filed 2024·Granted Aug 26, 2025·0 cites·53 claims
- 0782US2023406830A1[6,6] fused bicyclic hdac8 inhibitorsVALO HEALTH INC·Filed 2023·Application pending·0 cites
- 0879US2024150349A1Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0978US11292791B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·20 claims
- 1077US2025188079A1Inhibiting cyclic amp-responsive element-binding protein (creb)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1174US12378242B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·19 claims
- 1274US2024279224A1Quinolines and azaquinolines as inhibitors of cd38BOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1373US11787803B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·0 cites·20 claims
- 1463US2024101540A1Targeted protein degradation of parp14 for use in therapyRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1562US12351577B2Inhibiting cyclic AMP-responsive element-binding protein (CREB)FORMA THERAPEUTICS INC·Filed 2020·Granted Jul 8, 2025·0 cites·19 claims
- 1650US12162888B2Carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Dec 10, 2024·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Jennifer R. Downing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →